The global pharmaceutical logistics market size was exhibited at USD 84.39 billion in 2022 and is projected to hit around USD 189.05 billion by 2032, growing at a CAGR of 8.4% during the forecast period 2023 to 2032.
Key Pointers:
Pharmaceutical Logistics Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 91.48 Billion |
Market Size by 2032 |
USD 189.05 Billion |
Growth Rate From 2023 to 2032 |
CAGR of 8.4% |
Base Year |
2022 |
Forecast Period |
2023 to 2032 |
Segments Covered |
Type, Component, Application, Procedure |
Market Analysis (Terms Used) |
Value (US$ Million/Billion) or (Volume/Units) |
Regional Scope |
North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key Companies Profiled |
FedEx, Agility, CEVA Logistics, Deutsche Post AG, VersaCold Logistics Services, LifeConEx, Air Canada, United Parcel Service of America Inc., DB Schenker, Marken. |
The market growth is primarily driven by the rising demand for a variety of drugs as a result of increasing cases of chronic and lifestyle-related diseases. The market is expected to witness a high growth rate in cold-chain and non-cold chain pharmaceutical logistics owing to the impact of COVID-19 across the globe. During this pandemic situation, the government and officials across countries are primarily focusing on preventive measures and the treatment of patients. The import and export of various medicines to treat coronavirus are increasing across all countries, including U.S. and China.
Along with international trade, the nationwide logistics of drugs are also expected to increase to fulfill the rising demand from all the hospitals and medical establishments. Additionally, the U.S. Food and Drug Administration (FDA) and other healthcare agencies across various countries, such as India, China, and the U.K. approved the emergency use of COVID-19 vaccines. This, in turn, is expected to increase the global trade of vaccines in many countries, including the U.S. and India. Such increased trade of drugs and medicines across countries is expected to drive the market from 2023 to 2030.
Pharmaceutical logistics is an integral part of the healthcare system, as careful handling and transportation of pharmaceutical products are of utmost importance. Therefore, the equipment and staff services involved in the pharma supply chain are highly expensive. The latest trend gaining momentum in the market is consolidation among the pharma companies to expand their business and global presence. Technological advancements, such as cloud-based supply chain functions and blockchain technology, which provide accurate and real-time data of operations, will also have a positive impact on market growth. Additionally, these technologies also offer predictive analytics to identify demand and supply chain optimization and risk management. Identifying risks and preventing them helps companies increase productivity, efficiency, and process optimization of their businesses.
The market in Asia Pacific is projected to exhibit the highest CAGR from 2023 to 2032 owing to an increasing financial budget for the healthcare sector in several emerging countries of the region. Additionally, the soaring consumer spending in Over the Counter (OTC) pharmaceutical products is further boost the regional market growth over the forecast period.
Some of the prominent players in the Pharmaceutical Logistics Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Pharmaceutical Logistics market.
By Type
By Component
By Application
By Procedure
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Logistics Market
5.1. COVID-19 Landscape: Pharmaceutical Logistics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Logistics Market, By Type
8.1. Pharmaceutical Logistics Market, by Type, 2023-2032
8.1.1. Cold Chain Logistics
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Non-cold Chain Logistics
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Pharmaceutical Logistics Market, By Component
9.1. Pharmaceutical Logistics Market, by Component, 2023-2032
9.1.1. Storage
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Transportation
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Monitoring components
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Pharmaceutical Logistics Market, By Application Type
10.1. Pharmaceutical Logistics Market, by Application Type, 2023-2032
10.1.1. Bio Pharma
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Chemical Pharma
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Speciality Pharma
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Pharmaceutical Logistics Market, By Procedure Type
11.1. Pharmaceutical Logistics Market, by Procedure Type, 2023-2032
11.1.1. Picking
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Storage
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Retrieval Systems
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Handling Systems
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Pharmaceutical Logistics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Component (2020-2032)
12.1.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Component (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Component (2020-2032)
12.2.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Component (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Component (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Component (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Component (2020-2032)
12.3.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Component (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Component (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Component (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Component (2020-2032)
12.4.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Component (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Component (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Component (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Component (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Component (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)
Chapter 13. Company Profiles
13.1. FedEx
13.1.1. Company Overview
13.1.2. Product Offering
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Agility
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. CEVA Logistics
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Deutsche Post AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. VersaCold Logistics Services
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. LifeConEx
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Air Canada
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. United Parcel Service of America Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. DB Schenker
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Marken
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms